To Assess Compliance With a Once-daily Regimen of Lamivudine, Efavirenz and Didanosine

This study has been completed.
Merck Sharp & Dohme Corp.
Dohme Australia
Information provided by:
Bristol-Myers Squibb Identifier:
First received: September 12, 2005
Last updated: April 8, 2011
Last verified: April 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2006
  Primary Completion Date: December 2006 (Final data collection date for primary outcome measure)